Molecules/DARATUMUMAB

DARATUMUMAB

Molecular Identity

AntibodyApprovedFirst approved 2015

Mechanism of action: Lymphocyte differentiation antigen CD38 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

3003-005DARATUMUMABDARATUMUMAB COMPONENT OF DARZALEX FASPRODARATUMUMAB-FIHJDARZALEXHuMax-CD38HUMAX-CD 38HUMAXCD38

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to DARATUMUMAB

Loading drug network...